# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
RBC Capital analyst Sean Dodge maintains Avid Bioservices (NASDAQ:CDMO) with a Outperform and raises the price target from $...
Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(...
Stephens & Co. analyst Jacob Johnson maintains Avid Bioservices (NASDAQ:CDMO) with a Overweight and lowers the price tar...
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 250 points on Thursday. The Dow tr...
Avid Bioservices' Q3 fiscal 2024 report: $33.8 million revenues, 11% Y/Y decrease, $41 million new orders, $206 million bac...
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-exp...